Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease

References

Page 1

	Year	Citations
Clinical diagnosis of Alzheimer's disease Guy M. McKhann, David A. Drachman, Marshall Folstein, Neurology	1984	27.8K
The Neuropsychiatric Inventory Jeffrey L. Cummings, Michael S. Mega, Kevin F. Gray, Neurology	1994	7.4K
Performance‐Oriented Assessment of Mobility Problems in Elderly Patients Mary E. Tinetti Journal of the American Geriatrics Society Elderly PatientsGeriatricsRehabilitationHuman MovementGeriatric Assessment	1986	3.3K
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease Martha Storandt, J. Philip Miller, Daniel W. McKeel, Archives of Neurology	2001	1.8K
Paroxetine for the Prevention of Depression Induced by High-Dose Interferon Alfa Dominique L. Musselman, David H. Lawson, Jane F. Gumnick, New England Journal of Medicine	2001	1.1K
Mini-Mental State Examination (MMSE) J R Cockrell, Marshal F. Folstein NeuropsychologyPsychiatric EvaluationPsychiatryMemory AssessmentPsychology	2001	662
Production of superoxide anions by a CNS macrophage, the microglia Carol A. Colton, Daniel L. Gilbert FEBS Letters ImmunologyRedox BiologyCellular PhysiologyReactive Oxygen IntermediateOxidative Stress	1987	614
Intrathecal inflammation precedes development of Alzheimer's disease E. Tarkowski Journal of Neurology Neurosurgery & Psychiatry	2003	492
Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices Joachim Bauer, Sylvia Strauss, Ursula Schreiter-Gasser, FEBS Letters App ProcessingImmunologyNeurochemical BiomarkersAmyloid Precursor ProteinNeuroinflammation	1991	482
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy Lucile Capuron, Alain Ravaud, P.J. Neveu, Molecular Psychiatry Serum Tryptophan ConcentrationsPsychoneuroimmunologyPsychiatryMood SymptomImmunology	2002	466

Page 1